1Waekemagel A,Legat FJ,Hofer A,et al.Psoralen plus UVA vs.UVB-311 nm for the treatment of lichen planus.Photodermatol Photoimmunol Photomed 2007;23:15-19.
6Pisking,Tursen U,Sylva-steenland RM,et al.Clinical improvement in chronic P laque-type P soriasis lesions after narrowband UVB therapy is accompanied by a dercrease in the exp ression of IFN-gamma inducers IL-12,IL-18 and IL-23.Exp Dermatol 2004;13(12):764-772.
1[1]Gilhar A, Pillar T, Winterstein G, et al. The pathogenesis of lichen planus[J]. Br J Dermatol, 1989,120(4):541- 544.
2[2]Eisen D. Hydroxychloroquine sulfate(Plaquenil) improves oral lichen planus: An open trial[J]. J Am Acad Dermatol, 1993,28(4):609- 612.
3[3]Chieregato G, Peroni A, Castellani L, et al. Effects of hydroxychloroquine on ' band test' in discoid lupus erythematosus[J]. Dermatologica, 1990,180(3):130- 132.
4[4]Furner BB.Treatment of subacute cutaneous lupus erythematosus[J]. Int J Dermatol, 1990, 29(8):542- 547.
5[5]Jimenez- Alonso J, Tercedor J, Jaimez L, et al. Antimalarial drug-induced aquagenic- type pruritus in patients with lupus[J]. Arthritis Rheum, 1998,41(4):744- 745.
6[6]Felson DT, Anderson JJ, Meenan RF. Use of short- term efficacy/toxicity tradeoffs to select second- line drugs in rheumatoid arthritis.A metaanalysis of published clinical trials[J]. Arthritis Rheum, 1992,35(10):1117- 1125.
7Bandow GD,Koo JY.Narrow-band ultraviolet B radiation:a review of the curren tliterature.Int J Dermatol 2004;43(8):555-561.
8Wackernagel A,Legat FJ,Hofer A,et al.Psoralen plus UVA vs.UVB-311 nm for the treatment of lichen planus.Photodermatol Photoimmunol Photomed 2007;23:15-19.
9Gomes MA,Fernandez Bussy R,Schmitt D,et al.Cutaneous Immunocompetent cells Phenotype and peripheral T cell subpopulations Ratio in active lichen planus.J Invest Dermatol 1982;78:334-336.
10Panfilis DG,Manara GC,Ferrari C,et al.Imbalance in phenotypic expression of T cell subpopulations during different evolutional stages of lichen planus lesions.Acta Derm Venerol 1983 ;63:369-370.
2Lehman JS, Tollefson MM, Gibson LE. Lichen planus[J]. Int J Dermatol, 2009, 48: 682-694.
3Vazquez-Lopez F, G6mez-Dlez S, Sainchez J, et al. Dermoscopy of active lichen planus[J]. Arch Dermatol, 2007, 143: 1092.
4Liebman TN, Rabinovitz HS, Dusza SW, et al. White shiny structures: dermoscopic features revealed under polarized light [J]. J Eur Acad Demmtol Venereol, 2011,26:1493-1497.
5Vazquez-Lopez F, Vidal AM, Zalaudek I. Dermoscopic subpatterns of ashy dermatosis related to lichen planus[J]. Arch Dermatol, 2010, 146:110.
6Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus [J]. Am Faro Physician, 2011, 84: 53-60.
7Asch S, Goldenberg G. Systemic treatment of cutaneous lichen planus: an update[J]. Cutis, 2011, 87: 129-134.
8Bhuiyan I. Comparative efficacy of hydroxychloroquine and griseo- fulvin in the treatment of lichen planus [J]. J Pakistan Associa Der- matol, 2010, 20: 79-83.
9Byrd JA, Davis MD, Bruce A J, et al. Response of oral lichen planus to topical tacrolimus in 37 patients[J]. Arch Dermatol, 2004, 140: 1508-1512.
10Yamanaka KI, Kakeda M, Kitagawa Ⅱ, et al. 1, 24-Dihydroxyvi- tanmin D3 (tacaleitol) prevens skin T-cell infiltration[J]. Br J Der- matol, 2010,162:1206-1215.
